Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress

Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress

Peptide–drug conjugates (PDCs) have emerged as a next-generation therapeutic platform, combining the target specificity of peptides with the pharmacological potency of small-molecule drugs. As an evolution beyond antibody–drug conjugates (ADCs), PDCs offer distinct advantages, including enhanced cel...

Full description

Saved in:
Bibliographic Details
Main Authors: Krishna Jadhav, Ashwin Abhang, Eknath B. Kole, Dipak Gadade, Apurva Dusane, Aditya Iyer, Ankur Sharma, Saroj Kumar Rout, Amol D. Gholap, Jitendra Naik, Rahul K. Verma, Satish Rojekar
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Bioengineering
Subjects:
peptide–drug conjugates
peptide
linkers
targeted therapeutics
stability
theranostic
Online Access:https://www.mdpi.com/2306-5354/12/5/481
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items